On April 10, 2025, Seres Therapeutics' stockholders approved the 2025 Incentive Award Plan allowing for the issuance of 44,604,870 shares and a reverse stock split at a ratio of 1-for-20, effective April 21, 2025.
AI Assistant
SERES THERAPEUTICS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.